Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DMK

DMK Pharmaceuticals (DMK) Stock Price, News & Analysis

DMK Pharmaceuticals logo

About DMK Pharmaceuticals Stock (NASDAQ:DMK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.04
$0.58
52-Week Range
N/A
Volume
24.16 million shs
Average Volume
1.16 million shs
Market Capitalization
$2.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DMK Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DMK Stock News Headlines

Trump’s $100 Trillion Land Rush Is On
What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.
SEC hits ex-pharma CFO with sanction over fraud charges
Adamis Pharmaceuticals Corp (CY3.MU)
See More Headlines

DMK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that DMK Pharmaceuticals investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Sangamo Therapeutics (SGMO) and Bakkt (BKKT).

Company Calendar

Today
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DMK
CIK
887247
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.48 million
Net Margins
-630.85%
Pretax Margin
-600.29%
Return on Equity
N/A
Return on Assets
-251.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.58
Quick Ratio
0.54

Sales & Book Value

Annual Sales
$3.62 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.38) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,102,000
Free Float
9,506,000
Market Cap
$2.34 million
Optionable
No Data
Beta
1.11
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:DMK) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners